The role of β-arrestins in cancer

Progress in Molecular Biology and Translational Science

Volumn 118, Issue , 2013, Pages 395-411

  Sobolesky, Philip Michael ^a   Moussa, Omar ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879083783     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394440-5.00015-2     Document Type: Chapter

References (86)

1. L.S. Barak, S.S. Ferguson, J. Zhang, and M.G. Caron A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation J Biol Chem 272 44 1997 27497 27500
2. J.M. Beaulieu, and M.G. Caron Beta-arrestin goes nuclear Cell 123 5 2005 755 757
3. P. Dasgupta, W. Rizwani, and S. Pillai ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors J Natl Cancer Inst 103 4 2011 317 333
4. L. Rosano, R. Cianfrocca, and S. Masi Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis Proc Natl Acad Sci USA 106 8 2009 2806 2811
5. F.G. Buchanan, D.L. Gorden, P. Matta, Q. Shi, L.M. Matrisian, and R.N. DuBois Role of beta-arrestin 1 in the metastatic progression of colorectal cancer Proc Natl Acad Sci USA 103 5 2006 1492 1497
6. C.M. Vines, C.M. Revankar, and D.C. Maestas N-formyl peptide receptors internalize but do not recycle in the absence of arrestins J Biol Chem 278 43 2003 41581 41584
7. B.M. Wagener, N.A. Marjon, C.M. Revankar, and E.R. Prossnitz Adaptor protein-2 interaction with arrestin regulates GPCR recycling and apoptosis Traffic 10 9 2009 1286 1300
8. M.S. Khan, H. Devaraj, and N. Devaraj Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats Toxicol Appl Pharmacol 251 1 2011 85 94
9. Y. Li, X. Sun, and Y. Zhang Morphine promotes apoptosis via TLR2, and this is negatively regulated by beta-arrestin 2 Biochem Biophys Res Commun 378 4 2009 857 861
10. J. Moorman, Y. Zhang, and B. Liu HIV-1 gp120 primes lymphocytes for opioid-induced, beta-arrestin 2-dependent apoptosis Biochim Biophys Acta 1793 8 2009 1366 1371
11. T.J. Povsic, T.A. Kohout, and R.J. Lefkowitz Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis J Biol Chem 278 51 2003 51334 51339
12. Q. Shi, Y. Hou, Y. Yang, and G. Bai Protective effects of glycyrrhizin against beta(2)-adrenergic receptor agonist-induced receptor internalization and cell apoptosis Biol Pharm Bull 34 5 2011 609 617
13. X. Sun, Y. Zhang, and J. Wang Beta-arrestin 2 modulates resveratrol-induced apoptosis and regulation of Akt/GSK3ss pathways Biochim Biophys Acta 1800 9 2010 912 918
14. 2-induced apoptosis Cell Signal 21 7 2009 1195 1206
15. E. Reiter, and R.J. Lefkowitz GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling Trends Endocrinol Metab 17 4 2006 159 165
16. P. Penela, A. Elorza, S. Sarnago, and F. Mayor Jr. Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2 EMBO J 20 18 2001 5129 5138
17. W. Chen, L.A. Hu, and M.V. Semenov beta-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins Proc Natl Acad Sci USA 98 26 2001 14889 14894
18. J. Kang, Y. Shi, and B. Xiang A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription Cell 123 5 2005 833 847
19. S.A. Laporte, R.H. Oakley, J.A. Holt, L.S. Barak, and M.G. Caron The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits J Biol Chem 275 30 2000 23120 23126
20. K.L. Pierce, and R.J. Lefkowitz Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors Nat Rev Neurosci 2 10 2001 727 733
21. R.J. Lefkowitz, and S.K. Shenoy Transduction of receptor signals by beta-arrestins Science 308 5721 2005 512 517
22. J.L. Parent, P. Labrecque, M.J. Orsini, and J.L. Benovic Internalization of the TXA2 receptor alpha and beta isoforms. Role of the differentially spliced cooh terminus in agonist-promoted receptor internalization J Biol Chem 274 13 1999 8941 8948
23. J.L. Parent, P. Labrecque, M. Driss Rochdi, and J.L. Benovic Role of the differentially spliced carboxyl terminus in thromboxane A2 receptor trafficking: identification of a distinct motif for tonic internalization J Biol Chem 276 10 2001 7079 7085
24. G. Laroche, M.D. Rochdi, S.A. Laporte, and J.L. Parent Involvement of actin in agonist-induced endocytosis of the G protein-coupled receptor for thromboxane A2: overcoming of actin disruption by arrestin-3 but not arrestin-2 J Biol Chem 280 24 2005 23215 23224
25. L.P. Kelley-Hickie, and B.T. Kinsella Homologous desensitization of signalling by the beta (beta) isoform of the human thromboxane A2 receptor Biochim Biophys Acta 1761 9 2006 1114 1131
26. K.S. Park, S.H. Jeon, J.W. Oh, and K.Y. Choi p21Cip/WAF1 activation is an important factor for the ERK pathway dependent anti-proliferation of colorectal cancer cells Exp Mol Med 36 6 2004 557 562
27. K.S. Park, Y. Ahn, J.A. Kim, M.S. Yun, B.L. Seong, and K.Y. Choi Extracellular zinc stimulates ERK-dependent activation of p21(Cip/WAF1) and inhibits proliferation of colorectal cancer cells Br J Pharmacol 137 5 2002 597 607
28. X.Z. Ding, and T.E. Adrian MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1 Biochem Biophys Res Commun 282 2 2001 447 453
29. C.L. Xu, X.L. Lu, X.N. Yan, H.L. Wang, and S.Q. Chen Effects of PI3K/Akt/NF-kappaB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer Zhonghua fu chan ke za zhi 47 2 2012 134 138
30. Y. Wei, Z. Zhang, and H. Liao Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation Oncol Rep 27 2 2012 504 510
31. J.L. Qu, X.J. Qu, and M.F. Zhao Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation Dig Liver Dis 41 12 2009 875 880
32. Q. Meng, C. Xia, J. Fang, Y. Rojanasakul, and B.H. Jiang Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway Cell Signal 18 12 2006 2262 2271
33. K.L. Pierce, L.M. Luttrell, and R.J. Lefkowitz New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades Oncogene 20 13 2001 1532 1539
34. K.S. Chun, H.C. Lao, and R. Langenbach The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and {beta}-arrestin1-dependent signaling pathways J Biol Chem 285 51 2010 39672 39681
35. P. Dasgupta, S. Rastogi, and S. Pillai Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways J Clin Invest 116 8 2006 2208 2217
36. A.M. Fong, R.T. Premont, R.M. Richardson, Y.R. Yu, R.J. Lefkowitz, and D.D. Patel Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice Proc Natl Acad Sci USA 99 11 2002 7478 7483
37. F.M. Decaillot, M.A. Kazmi, Y. Lin, S. Ray-Saha, T.P. Sakmar, and P. Sachdev CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration J Biol Chem 286 37 2011 32188 32197
38. Y. Sun, Z. Cheng, L. Ma, and G. Pei Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation J Biol Chem 277 51 2002 49212 49219
39. L. Girnita, S.K. Shenoy, and B. Sehat {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase J Biol Chem 280 26 2005 24412 24419
40. L. Girnita, S.K. Shenoy, and B. Sehat Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression J Biol Chem 282 15 2007 11329 11338
41. L. Zou, R. Yang, J. Chai, and G. Pei Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis FASEB J 22 2 2008 355 364
42. T.T. Li, M. Alemayehu, and A.I. Aziziyeh Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells Mol Cancer Res 7 7 2009 1064 1077
43. S.K. Shenoy, S. Han, and Y.L. Zhao Beta-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression Oncogene 31 3 2012 282 292
44. L. Ge, S.K. Shenoy, R.J. Lefkowitz, and K. DeFea Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2 J Biol Chem 279 53 2004 55419 55424
45. P. Wang, and K.A. DeFea Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase Biochemistry 45 31 2006 9374 9385
46. K.A. DeFea, Z.D. Vaughn, E.M. O'Bryan, D. Nishijima, O. Dery, and N.W. Bunnett The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex Proc Natl Acad Sci USA 97 20 2000 11086 11091
47. C.M. Revankar, C.M. Vines, D.F. Cimino, and E.R. Prossnitz Arrestins block G protein-coupled receptor-mediated apoptosis J Biol Chem 279 23 2004 24578 24584
48. R.J. Lefkowitz, K. Rajagopal, and E.J. Whalen New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors Mol Cell 24 5 2006 643 652
49. H. Li, X. Sun, and G. LeSage beta-Arrestin 2 regulates Toll-like receptor 4-mediated apoptotic signalling through glycogen synthase kinase-3beta Immunology 130 4 2010 556 563
50. S. Ahn, J. Kim, M.R. Hara, X.R. Ren, and R.J. Lefkowitz {beta}-Arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation J Biol Chem 284 13 2009 8855 8865
51. B. Luan, Z. Zhang, Y. Wu, J. Kang, and G. Pei Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation EMBO J 24 24 2005 4237 4246
52. F. Schaffner, and W. Ruf Tissue factor and PAR2 signaling in the tumor microenvironment Arterioscler Thromb Vasc Biol 29 12 2009 1999 2004
53. A. Boucharaba, B. Guillet, and F. Menaa Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms Oncol Res 18 4 2009 173 184
54. A. Boucharaba, C.M. Serre, J. Guglielmi, J.C. Bordet, P. Clezardin, and O. Peyruchaud The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases Proc Natl Acad Sci USA 103 25 2006 9643 9648
55. O. Peyruchaud, A. Boucharaba, J.S. Saulnier-Blache, and P. Clezardin Lysophosphatidic acid: a new link between blood platelets and bone metastasis Med Sci 21 4 2005 353 355
56. A. Boucharaba, C.M. Serre, and S. Gres Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer J Clin Invest 114 12 2004 1714 1725
57. C. Bonnans, M. Flaceliere, and F. Grillet Essential requirement for beta-arrestin2 in mouse intestinal tumors with elevated Wnt signaling Proc Natl Acad Sci USA 109 8 2012 3047 3052
58. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 1 2012 10 29
59. C. Heeschen, J.J. Jang, and M. Weis Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis Nat Med 7 7 2001 833 839
60. Z. Wu, W. Tong, Z. Tan, S. Wang, and P. Lin The clinical significance of beta-arrestin 2 expression in the serum of non-small cell lung cancer patients Zhongguo Fei Ai Za Zhi 14 6 2011 497 501
61. M.T. Wang, K.V. Honn, and D. Nie Cyclooxygenases, prostanoids, and tumor progression Cancer Metastasis Rev 26 3-4 2007 525 534
62. C. Schneider, and A. Pozzi Cyclooxygenases and lipoxygenases in cancer Cancer Metastasis Rev 30 3-4 2011 277 294
63. H. Achiwa, Y. Yatabe, and T. Hida Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas Clin Cancer Res 5 5 1999 1001 1005
64. A. Ristimaki, A. Sivula, and J. Lundin Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res 62 3 2002 632 635
65. J.I. Kim, V. Lakshmikanthan, N. Frilot, and Y. Daaka Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome Mol Cancer Res 8 4 2010 569 577
66. E.B. Avritscher, C.D. Cooksley, and H.B. Grossman Clinical model of lifetime cost of treating bladder cancer and associated complications Urology 68 3 2006 549 553
67. O. Moussa, A.W. Ashton, and M. Fraig Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis Cancer Res 68 11 2008 4097 4104
68. K.R. Schultz, W.P. Bowman, and A. Aledo Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study J Clin Oncol 27 31 2009 5175 5181
69. H. Liu, J. Long, and P.H. Zhang Elevated beta-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia Int J Hematol 93 4 2011 494 501
70. M. Fereshteh, T. Ito, and J.J. Kovacs beta-Arrestin2 mediates the initiation and progression of myeloid leukemia Proc Natl Acad Sci USA 109 31 2012 12532 12537
71. B.J. Feldman, and D. Feldman The development of androgen-independent prostate cancer Nat Rev Cancer 1 1 2001 34 45
72. V. Lakshmikanthan, L. Zou, and J.I. Kim Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer Proc Natl Acad Sci USA 106 23 2009 9379 9384
73. M. Hennenberg, B. Schlenker, and A. Roosen beta-Arrestin-2 is expressed in human prostate smooth muscle and a binding partner of alpha1A-adrenoceptors World J Urol 29 2 2011 157 163
74. R.S. Turley, E.C. Finger, N. Hempel, T. How, T.A. Fields, and G.C. Blobe The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer Cancer Res 67 3 2007 1090 1098
75. K. Mythreye, and G.C. Blobe The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42 Proc Natl Acad Sci USA 106 20 2009 8221 8226
76. P. Zhang, X. He, J. Tan, X. Zhou, and L. Zou beta-Arrestin2 mediates beta-2 adrenergic receptor signaling inducing prostate cancer cell progression Oncol Rep 26 6 2011 1471 1477
77. E.L. Heinrich, W. Lee, J. Lu, A.M. Lowy, and J. Kim Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells J Transl Med 10 2012 68
78. X. Shen, A. Artinyan, D. Jackson, R.M. Thomas, A.M. Lowy, and J. Kim Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways Pancreas 39 1 2010 81 87
79. S.P. Thayer, M.P. di Magliano, and P.W. Heiser Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis Nature 425 6960 2003 851 856
80. W. Chen, X.R. Ren, and C.D. Nelson Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2 Science 306 5705 2004 2257 2260
81. J.W. Mandell, G. Glass, and E.P. Gianchandani Dephosphorylation of beta-arrestin 1 in glioblastomas J Neuropathol Exp Neurol 68 5 2009 535 541
82. A.M. Michal, A.R. Peck, and T.H. Tran Differential expression of arrestins is a predictor of breast cancer progression and survival Breast Cancer Res Treat 130 3 2011 791 807
83. J.B. Rubin, A.L. Kung, and R.S. Klein A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors Proc Natl Acad Sci USA 100 23 2003 13513 13518
84. S. Gravel, C. Malouf, and P.E. Boulais The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains J Biol Chem 285 49 2010 37939 37943
85. V. Odemis, J. Lipfert, and R. Kraft The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells Glia 60 3 2012 372 381
86. K. Lundgren, N.P. Tobin, and S. Lehn Stromal expression of beta-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer J Mol Diagn 13 3 May 2011 340 351